Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells
The urokinase receptor (uPAR) is a glycosylphosphatidylinositol (GPI)-anchored protein that promotes tissue remodeling, tumor cell adhesion, migration and invasion. uPAR mediates degradation of the extracellular matrix through protease recruitment and enhances cell adhesion, migration and signaling...
Uložené v:
| Vydané v: | eLife Ročník 6 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
eLife Science Publications, Ltd
29.08.2017
eLife Sciences Publications Ltd eLife Sciences Publications, Ltd |
| Predmet: | |
| ISSN: | 2050-084X, 2050-084X |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | The urokinase receptor (uPAR) is a glycosylphosphatidylinositol (GPI)-anchored protein that promotes tissue remodeling, tumor cell adhesion, migration and invasion. uPAR mediates degradation of the extracellular matrix through protease recruitment and enhances cell adhesion, migration and signaling through vitronectin binding and interactions with integrins. Full-length uPAR is released from the cell surface, but the mechanism and significance of uPAR shedding remain obscure. Here we identify transmembrane glycerophosphodiesterase GDE3 as a GPI-specific phospholipase C that cleaves and releases uPAR with consequent loss of function, whereas its homologue GDE2 fails to attack uPAR. GDE3 overexpression depletes uPAR from distinct basolateral membrane domains in breast cancer cells, resulting in a less transformed phenotype, it slows tumor growth in a xenograft model and correlates with prolonged survival in patients. Our results establish GDE3 as a negative regulator of the uPAR signaling network and, furthermore, highlight GPI-anchor hydrolysis as a cell-intrinsic mechanism to alter cell behavior.
Every process in the body, from how cells divide to how they move around, is tightly regulated. For example, cells only migrate when they receive the correct signals from their environment. These signals are recognised by receptor proteins that sit on the cell surface and connect the outside signal with the cell’s response. However, in cancer cells, these processes are out of control, which is why cancer cells can grow very quickly or spread to many different parts of the body.
One important receptor protein is the urokinase receptor, which helps to reorganize the tissue, for example, when wounds heal, but also enables cancer cells to grow and spread. A special feature of urokinase receptor is the way it is connected to the cell surface, namely through a molecule that acts as an anchor, called the GPI anchor. The urokinase receptor and some other GPI-anchored proteins can be released from their anchor. However, until now it was not clear why and how the urokinase receptor is released from cells, or how losing the receptor affects the cell.
Now, van Veen, Matas-Rico et al. studied breast cancer cells, and discovered that an enzyme called GDE3 cuts the urokinase receptor off its GPI anchor to release the receptor from the cells. However, when breast cancer cells shed the urokinase receptor, they also lost the receptor from the cell surface in specific areas. As a result, the receptor could not work anymore. When breast cancer cells were experimentally modified to produce high levels of GDE3, the cancer cells became less mobile and aggressive.
Van Veen, Matas-Rico et al. then implanted ‘normal’ breast cancer cells, and breast cancer cells with extra GDE3 into mice, and observed that the tumors of mice with additional GDE3 grew less quickly. Moreover, breast cancer patients with high levels of GDE3 tend to live longer than patients with low levels of GDE3. These results suggest that the enzyme GDE3 can suppress tumor growth.
These findings uncover a new way how cells can alter their behavior, namely by cleaving GPI anchors at the cell surface. Future experiments will need to address how GDE3 itself is controlled, and if it releases other GPI-anchored proteins from cells. Once we know how to increase GDE3 activity in tumor cells, the new knowledge could one day lead to therapies to help patients with cancer. |
|---|---|
| AbstractList | The urokinase receptor (uPAR) is a glycosylphosphatidylinositol (GPI)-anchored protein that promotes tissue remodeling, tumor cell adhesion, migration and invasion. uPAR mediates degradation of the extracellular matrix through protease recruitment and enhances cell adhesion, migration and signaling through vitronectin binding and interactions with integrins. Full-length uPAR is released from the cell surface, but the mechanism and significance of uPAR shedding remain obscure. Here we identify transmembrane glycerophosphodiesterase GDE3 as a GPI-specific phospholipase C that cleaves and releases uPAR with consequent loss of function, whereas its homologue GDE2 fails to attack uPAR. GDE3 overexpression depletes uPAR from distinct basolateral membrane domains in breast cancer cells, resulting in a less transformed phenotype, it slows tumor growth in a xenograft model and correlates with prolonged survival in patients. Our results establish GDE3 as a negative regulator of the uPAR signaling network and, furthermore, highlight GPI-anchor hydrolysis as a cell-intrinsic mechanism to alter cell behavior.
Every process in the body, from how cells divide to how they move around, is tightly regulated. For example, cells only migrate when they receive the correct signals from their environment. These signals are recognised by receptor proteins that sit on the cell surface and connect the outside signal with the cell’s response. However, in cancer cells, these processes are out of control, which is why cancer cells can grow very quickly or spread to many different parts of the body.
One important receptor protein is the urokinase receptor, which helps to reorganize the tissue, for example, when wounds heal, but also enables cancer cells to grow and spread. A special feature of urokinase receptor is the way it is connected to the cell surface, namely through a molecule that acts as an anchor, called the GPI anchor. The urokinase receptor and some other GPI-anchored proteins can be released from their anchor. However, until now it was not clear why and how the urokinase receptor is released from cells, or how losing the receptor affects the cell.
Now, van Veen, Matas-Rico et al. studied breast cancer cells, and discovered that an enzyme called GDE3 cuts the urokinase receptor off its GPI anchor to release the receptor from the cells. However, when breast cancer cells shed the urokinase receptor, they also lost the receptor from the cell surface in specific areas. As a result, the receptor could not work anymore. When breast cancer cells were experimentally modified to produce high levels of GDE3, the cancer cells became less mobile and aggressive.
Van Veen, Matas-Rico et al. then implanted ‘normal’ breast cancer cells, and breast cancer cells with extra GDE3 into mice, and observed that the tumors of mice with additional GDE3 grew less quickly. Moreover, breast cancer patients with high levels of GDE3 tend to live longer than patients with low levels of GDE3. These results suggest that the enzyme GDE3 can suppress tumor growth.
These findings uncover a new way how cells can alter their behavior, namely by cleaving GPI anchors at the cell surface. Future experiments will need to address how GDE3 itself is controlled, and if it releases other GPI-anchored proteins from cells. Once we know how to increase GDE3 activity in tumor cells, the new knowledge could one day lead to therapies to help patients with cancer. The urokinase receptor (uPAR) is a glycosylphosphatidylinositol (GPI)-anchored protein that promotes tissue remodeling, tumor cell adhesion, migration and invasion. uPAR mediates degradation of the extracellular matrix through protease recruitment and enhances cell adhesion, migration and signaling through vitronectin binding and interactions with integrins. Full-length uPAR is released from the cell surface, but the mechanism and significance of uPAR shedding remain obscure. Here we identify transmembrane glycerophosphodiesterase GDE3 as a GPI-specific phospholipase C that cleaves and releases uPAR with consequent loss of function, whereas its homologue GDE2 fails to attack uPAR. GDE3 overexpression depletes uPAR from distinct basolateral membrane domains in breast cancer cells, resulting in a less transformed phenotype, it slows tumor growth in a xenograft model and correlates with prolonged survival in patients. Our results establish GDE3 as a negative regulator of the uPAR signaling network and, furthermore, highlight GPI-anchor hydrolysis as a cell-intrinsic mechanism to alter cell behavior. Every process in the body, from how cells divide to how they move around, is tightly regulated. For example, cells only migrate when they receive the correct signals from their environment. These signals are recognised by receptor proteins that sit on the cell surface and connect the outside signal with the cell’s response. However, in cancer cells, these processes are out of control, which is why cancer cells can grow very quickly or spread to many different parts of the body. One important receptor protein is the urokinase receptor, which helps to reorganize the tissue, for example, when wounds heal, but also enables cancer cells to grow and spread. A special feature of urokinase receptor is the way it is connected to the cell surface, namely through a molecule that acts as an anchor, called the GPI anchor. The urokinase receptor and some other GPI-anchored proteins can be released from their anchor. However, until now it was not clear why and how the urokinase receptor is released from cells, or how losing the receptor affects the cell. Now, van Veen, Matas-Rico et al. studied breast cancer cells, and discovered that an enzyme called GDE3 cuts the urokinase receptor off its GPI anchor to release the receptor from the cells. However, when breast cancer cells shed the urokinase receptor, they also lost the receptor from the cell surface in specific areas. As a result, the receptor could not work anymore. When breast cancer cells were experimentally modified to produce high levels of GDE3, the cancer cells became less mobile and aggressive. Van Veen, Matas-Rico et al. then implanted ‘normal’ breast cancer cells, and breast cancer cells with extra GDE3 into mice, and observed that the tumors of mice with additional GDE3 grew less quickly. Moreover, breast cancer patients with high levels of GDE3 tend to live longer than patients with low levels of GDE3. These results suggest that the enzyme GDE3 can suppress tumor growth. These findings uncover a new way how cells can alter their behavior, namely by cleaving GPI anchors at the cell surface. Future experiments will need to address how GDE3 itself is controlled, and if it releases other GPI-anchored proteins from cells. Once we know how to increase GDE3 activity in tumor cells, the new knowledge could one day lead to therapies to help patients with cancer. The urokinase receptor (uPAR) is a glycosylphosphatidylinositol (GPI)-anchored protein that promotes tissue remodeling, tumor cell adhesion, migration and invasion. uPAR mediates degradation of the extracellular matrix through protease recruitment and enhances cell adhesion, migration and signaling through vitronectin binding and interactions with integrins. Full-length uPAR is released from the cell surface, but the mechanism and significance of uPAR shedding remain obscure. Here we identify transmembrane glycerophosphodiesterase GDE3 as a GPI-specific phospholipase C that cleaves and releases uPAR with consequent loss of function, whereas its homologue GDE2 fails to attack uPAR. GDE3 overexpression depletes uPAR from distinct basolateral membrane domains in breast cancer cells, resulting in a less transformed phenotype, it slows tumor growth in a xenograft model and correlates with prolonged survival in patients. Our results establish GDE3 as a negative regulator of the uPAR signaling network and, furthermore, highlight GPI-anchor hydrolysis as a cell-intrinsic mechanism to alter cell behavior. The urokinase receptor (uPAR) is a glycosylphosphatidylinositol (GPI)-anchored protein that promotes tissue remodeling, tumor cell adhesion, migration and invasion. uPAR mediates degradation of the extracellular matrix through protease recruitment and enhances cell adhesion, migration and signaling through vitronectin binding and interactions with integrins. Full-length uPAR is released from the cell surface, but the mechanism and significance of uPAR shedding remain obscure. Here we identify transmembrane glycerophosphodiesterase GDE3 as a GPI-specific phospholipase C that cleaves and releases uPAR with consequent loss of function, whereas its homologue GDE2 fails to attack uPAR. GDE3 overexpression depletes uPAR from distinct basolateral membrane domains in breast cancer cells, resulting in a less transformed phenotype, it slows tumor growth in a xenograft model and correlates with prolonged survival in patients. Our results establish GDE3 as a negative regulator of the uPAR signaling network and, furthermore, highlight GPI-anchor hydrolysis as a cell-intrinsic mechanism to alter cell behavior.The urokinase receptor (uPAR) is a glycosylphosphatidylinositol (GPI)-anchored protein that promotes tissue remodeling, tumor cell adhesion, migration and invasion. uPAR mediates degradation of the extracellular matrix through protease recruitment and enhances cell adhesion, migration and signaling through vitronectin binding and interactions with integrins. Full-length uPAR is released from the cell surface, but the mechanism and significance of uPAR shedding remain obscure. Here we identify transmembrane glycerophosphodiesterase GDE3 as a GPI-specific phospholipase C that cleaves and releases uPAR with consequent loss of function, whereas its homologue GDE2 fails to attack uPAR. GDE3 overexpression depletes uPAR from distinct basolateral membrane domains in breast cancer cells, resulting in a less transformed phenotype, it slows tumor growth in a xenograft model and correlates with prolonged survival in patients. Our results establish GDE3 as a negative regulator of the uPAR signaling network and, furthermore, highlight GPI-anchor hydrolysis as a cell-intrinsic mechanism to alter cell behavior. |
| Audience | Academic |
| Author | Matas-Rico, Elisa Stijf-Bultsma, Yvette van den Broek, Bram Sidenius, Nicolai Moolenaar, Wouter H Leyton-Puig, Daniela van Veen, Michiel van de Wetering, Koen Jalink, Kees Perrakis, Anastassis Kedziora, Katarzyna M De Lorenzi, Valentina |
| Author_xml | – sequence: 1 givenname: Michiel surname: van Veen fullname: van Veen, Michiel organization: Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands – sequence: 2 givenname: Elisa surname: Matas-Rico fullname: Matas-Rico, Elisa organization: Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands – sequence: 3 givenname: Koen surname: van de Wetering fullname: van de Wetering, Koen organization: Division of Molecular Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands – sequence: 4 givenname: Daniela surname: Leyton-Puig fullname: Leyton-Puig, Daniela organization: Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands – sequence: 5 givenname: Katarzyna M surname: Kedziora fullname: Kedziora, Katarzyna M organization: Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands – sequence: 6 givenname: Valentina surname: De Lorenzi fullname: De Lorenzi, Valentina organization: IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy – sequence: 7 givenname: Yvette surname: Stijf-Bultsma fullname: Stijf-Bultsma, Yvette organization: Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, Netherlands – sequence: 8 givenname: Bram surname: van den Broek fullname: van den Broek, Bram organization: Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands – sequence: 9 givenname: Kees surname: Jalink fullname: Jalink, Kees organization: Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands – sequence: 10 givenname: Nicolai surname: Sidenius fullname: Sidenius, Nicolai organization: IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy – sequence: 11 givenname: Anastassis orcidid: 0000-0002-1151-6227 surname: Perrakis fullname: Perrakis, Anastassis organization: Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, Netherlands – sequence: 12 givenname: Wouter H orcidid: 0000-0001-7545-198X surname: Moolenaar fullname: Moolenaar, Wouter H organization: Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28849762$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkttr2zAUxs3oWC_r096HYC8bI51k62K9FErYukDYxi6wNyHLx65SR_IkuzT__eSkHUmZQEgc_c53dKTvNDty3kGWvSL4QjBGP8DSNnCRF5zKZ9lJjhme4ZL-PtrbH2fnMa5wGoKWJZEvsuO8LKkUPD_Jbr9Aqwd7ByhAO3Zp6x3yDRqDv7VOxyluoB98QNokzg4bVG2QRtffFrPYg7GNNai_8THNzvZTxhxZh6oAOg7IaGcgIANdF19mzxvdRTh_WM-yX58-_px_ni2_Xi_mV8uZ4bgYZrqioE0ucSnLmsq6wlw0daUFgaIRJSu44ZQXoCUpiNQUMyKoTGeNqEupRXGWLXa6tdcr1Qe71mGjvLZqG_ChVToM1nSgGBa44ZSBEJim8pWuCGBe0yrFTUOS1uVOqx-rNdQG3BB0dyB6eOLsjWr9nWJMcFryJPD2QSD4PyPEQa1tnJ5DO_BjVEQWBUtT5Al98wRd-TG49FSJYpil38v3qFanBqxrfKprJlF1xfOCcczldO93B5TxboD7odVjjGrx4_sh-3q_x3_NPbokAWQHmOBjDNAoY4etVVJp2ymC1WRGtTWj2pox5bx_kvMo-z_6L_-43zA |
| CitedBy_id | crossref_primary_10_1016_j_tcb_2024_12_010 crossref_primary_10_1002_advs_202400700 crossref_primary_10_1126_scitranslmed_abq6492 crossref_primary_10_3390_cancers14143536 crossref_primary_10_1182_bloodadvances_2022008374 crossref_primary_10_1186_s40478_022_01376_x crossref_primary_10_1016_j_bbalip_2020_158761 crossref_primary_10_1242_jcs_235044 crossref_primary_10_3389_fcell_2022_818616 crossref_primary_10_1074_jbc_RA120_015278 crossref_primary_10_1247_csf_23016 crossref_primary_10_3389_fendo_2022_995972 crossref_primary_10_3390_metabo13030345 crossref_primary_10_3389_fonc_2021_752642 crossref_primary_10_3390_ijms22084111 crossref_primary_10_1074_jbc_RA120_014643 crossref_primary_10_1161_JAHA_119_015457 crossref_primary_10_3389_fcell_2021_732015 crossref_primary_10_1098_rsob_190290 crossref_primary_10_1159_000490118 crossref_primary_10_1126_sciadv_adt2724 crossref_primary_10_1002_1873_3468_14320 crossref_primary_10_1002_2211_5463_13617 crossref_primary_10_1016_j_addr_2020_08_006 crossref_primary_10_3390_ijms22031437 crossref_primary_10_1042_BST20191142 crossref_primary_10_1038_s41416_023_02379_8 crossref_primary_10_3390_molecules29153694 crossref_primary_10_3390_ijms23031587 crossref_primary_10_3389_fimmu_2024_1507476 |
| Cites_doi | 10.1194/jlr.R063313 10.1042/bj20031326 10.15252/embj.201387611 10.1083/jcb.152.6.1145 10.1074/jbc.M109.035444 10.1038/nrm2821 10.1038/nmeth.3213 10.1016/j.plipres.2011.05.002 10.1055/s-0033-1334485 10.1016/j.ccell.2016.08.016 10.1080/15384101.2016.1259894 10.7150/thno.12956 10.1093/emboj/cdg588 10.1111/febs.12699 10.1359/jbmr.070516 10.1016/j.dib.2015.08.027 10.1172/JCI116817 10.1126/science.aac7557 10.1016/S0021-9258(19)37176-5 10.1007/s10815-016-0745-x 10.1093/jnci/91.10.869 10.1200/JCO.2006.05.6853 10.1002/0471140864.ps1205s02 10.1182/blood.V96.13.4091 10.1074/jbc.M302867200 10.1126/science.1231143 10.1021/bi8006324 10.1111/j.1432-1033.1992.tb17200.x 10.1083/jcb.200702151 10.1016/S0143-4004(98)91043-8 10.1007/s10719-008-9116-x 10.1158/0008-5472.CAN-12-3526 10.1056/NEJMc1515787 10.1186/cc11434 10.1093/nar/gku936 10.2741/3392 10.2174/138161211796718233 10.1038/nature11003 10.1083/jcb.200612058 10.1126/science.1231921 10.1126/science.2017684 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2017 eLife Science Publications, Ltd. 2017, van Veen et al. This work is licensed under the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/3.0/ ) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2017, van Veen et al 2017 van Veen et al |
| Copyright_xml | – notice: COPYRIGHT 2017 eLife Science Publications, Ltd. – notice: 2017, van Veen et al. This work is licensed under the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/3.0/ ) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2017, van Veen et al 2017 van Veen et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7X7 7XB 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
| DOI | 10.7554/eLife.23649 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef Publicly Available Content Database MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2050-084X |
| ExternalDocumentID | oai_doaj_org_article_5070f645e7704c60bab1e06d4b70fcf1 PMC5576486 A623560691 28849762 10_7554_eLife_23649 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United States |
| GeographicLocations_xml | – name: United States |
| GrantInformation_xml | – fundername: ; grantid: Graduate Student Fellowship |
| GroupedDBID | 53G 5VS 7X7 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAKDD AAYXX ABUWG ACGFO ACGOD ACPRK ADBBV ADRAZ AENEX AFFHD AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CITATION DIK DWQXO EMOBN FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IEA IHR INH INR ISR ITC KQ8 LK8 M1P M2P M48 M7P M~E NQS OK1 PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO RHI RNS RPM UKHRP 3V. ALIPV CGR CUY CVF ECM EIF FRP NPM RHF 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c603t-ab4eac290898d49db067fdba71e3f78536c6463ea91319a4051749e3ff7d89a73 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 41 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000408627500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2050-084X |
| IngestDate | Fri Oct 03 12:53:15 EDT 2025 Tue Nov 04 01:55:07 EST 2025 Thu Sep 04 17:58:23 EDT 2025 Sat Nov 29 15:03:34 EST 2025 Tue Nov 11 10:10:54 EST 2025 Thu Nov 13 15:30:53 EST 2025 Wed Feb 19 02:43:05 EST 2025 Sat Nov 29 03:02:26 EST 2025 Tue Nov 18 21:46:41 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | cell biology signal transduction GDE3 cancer biology glycosylphosphatidylinositol human glycerophosphodiester phosphodiesterase |
| Language | English |
| License | http://creativecommons.org/licenses/by/4.0 This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c603t-ab4eac290898d49db067fdba71e3f78536c6463ea91319a4051749e3ff7d89a73 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors contributed equally to this work. Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, United States. University of North Carolina, Chapel Hill, United States. |
| ORCID | 0000-0002-1151-6227 0000-0001-7545-198X |
| OpenAccessLink | https://doaj.org/article/5070f645e7704c60bab1e06d4b70fcf1 |
| PMID | 28849762 |
| PQID | 1950548822 |
| PQPubID | 2045579 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_5070f645e7704c60bab1e06d4b70fcf1 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5576486 proquest_miscellaneous_1933593372 proquest_journals_1950548822 gale_infotracmisc_A623560691 gale_incontextgauss_ISR_A623560691 pubmed_primary_28849762 crossref_citationtrail_10_7554_eLife_23649 crossref_primary_10_7554_eLife_23649 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-08-29 |
| PublicationDateYYYYMMDD | 2017-08-29 |
| PublicationDate_xml | – month: 08 year: 2017 text: 2017-08-29 day: 29 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Cambridge |
| PublicationTitle | eLife |
| PublicationTitleAlternate | Elife |
| PublicationYear | 2017 |
| Publisher | eLife Science Publications, Ltd eLife Sciences Publications Ltd eLife Sciences Publications, Ltd |
| Publisher_xml | – name: eLife Science Publications, Ltd – name: eLife Sciences Publications Ltd – name: eLife Sciences Publications, Ltd |
| References | Matas-Rico (bib23) 2016; 30 Mann (bib22) 2004; 378 Madsen (bib20) 2007; 177 Stephens (bib40) 1999; 91 Maeda (bib21) 2011; 50 Ferraris (bib12) 2013; 39 Kjøller (bib18) 2001; 152 Mustjoki (bib29) 2000; 60 Haupt (bib14) 2012; 16 Kinoshita (bib17) 2016; 57 LeBeau (bib19) 2013; 73 Zhao (bib43) 2015; 5 Mehlert (bib25) 2009; 26 Cunningham (bib9) 2003; 22 Doering (bib10) 2001; Chapter 12 Park (bib30) 2013; 339 Matas-Rico (bib24) 2017; 16 Montuori (bib26) 2009; 14 Scallon (bib36) 1991; 252 Sidenius (bib38) 2000; 96 Barretina (bib1) 2012; 483 Blomen (bib2) 2015; 350 Hayek (bib15) 2016; 374 Høyer-Hansen (bib16) 1992; 267 Paulick (bib31) 2008; 47 Furlan (bib13) 2007; 22 Yang (bib42) 2015; 12 Boonstra (bib3) 2011; 17 Ferraris (bib11) 2014; 33 Pedersen (bib32) 1993; 92 Yanaka (bib41) 2003; 278 Shariat (bib37) 2007; 25 Brinkman (bib4) 2014; 42 Corda (bib7) 2009; 284 Smith (bib39) 2010; 11 Cong (bib6) 2013; 339 Munch (bib28) 2016; 33 Caiolfa (bib5) 2007; 179 Ploug (bib35) 1992; 208 Pierleoni (bib34) 1998; 19 Corda (bib8) 2014; 281 Multhaupt (bib27) 1994; 71 Persson (bib33) 2015; 5 20027185 - Nat Rev Mol Cell Biol. 2010 Jan;11(1):23-36 14609946 - EMBO J. 2003 Nov 17;22(22):5994-6003 12933806 - J Biol Chem. 2003 Oct 31;278(44):43595-602 14611645 - Biochem J. 2004 Mar 1;378(Pt 2):641-8 10340907 - J Natl Cancer Inst. 1999 May 19;91(10):869-74 27241529 - J Assist Reprod Genet. 2016 Aug;33(8):1017-25 2017684 - Science. 1991 Apr 19;252(5004):446-8 11110678 - Blood. 2000 Dec 15;96(13):4091-5 7933989 - Lab Invest. 1994 Sep;71(3):392-400 26516369 - Theranostics. 2015 Sep 13;5(12 ):1303-16 25549265 - Nat Methods. 2015 Jan;12(1):7-8 11156421 - Cancer Res. 2000 Dec 15;60(24):7126-32 24373430 - FEBS J. 2014 Feb;281(4):998-1016 27693046 - Cancer Cell. 2016 Oct 10;30(4):548-562 26962914 - N Engl J Med. 2016 Mar 3;374(9):891 21658410 - Prog Lipid Res. 2011 Oct;50(4):411-24 1325906 - Eur J Biochem. 1992 Sep 1;208(2):397-404 26504891 - Data Brief. 2015 Sep 04;5:107-13 17539736 - J Bone Miner Res. 2007 Sep;22(9):1387-96 17548516 - J Cell Biol. 2007 Jun 4;177(5):927-39 18429111 - Curr Protoc Protein Sci. 2001 May;Chapter 12:Unit 12.5 23400595 - Cancer Res. 2013 Apr 1;73(7):2070-81 17264329 - J Clin Oncol. 2007 Feb 1;25(4):349-55 23532573 - Semin Thromb Hemost. 2013 Jun;39(4):347-55 23287718 - Science. 2013 Feb 15;339(6121):819-23 26472760 - Science. 2015 Nov 27;350(6264):1092-6 1381366 - J Biol Chem. 1992 Sep 5;267(25):18224-9 18330699 - Glycoconj J. 2009 Nov;26(8):915-21 27860541 - Cell Cycle. 2017 Mar 4;16(5):388-389 26563290 - J Lipid Res. 2016 Jan;57(1):6-24 18557633 - Biochemistry. 2008 Jul 8;47(27):6991-7000 11257116 - J Cell Biol. 2001 Mar 19;152(6):1145-57 25168639 - EMBO J. 2014 Nov 3;33(21):2458-72 19273214 - Front Biosci (Landmark Ed). 2009 Jan 01;14:2494-503 23329048 - Science. 2013 Jan 18;339(6117):324-8 19596859 - J Biol Chem. 2009 Sep 11;284(37):24848-56 18056417 - J Cell Biol. 2007 Dec 3;179(5):1067-82 22460905 - Nature. 2012 Mar 28;483(7391):603-7 8227331 - J Clin Invest. 1993 Nov;92(5):2160-7 22824423 - Crit Care. 2012 Jul 23;16(4):R130 9778123 - Placenta. 1998 Sep;19(7):501-8 21711239 - Curr Pharm Des. 2011;17(19):1890-910 25300484 - Nucleic Acids Res. 2014 Dec 16;42(22):e168 |
| References_xml | – volume: 57 start-page: 6 year: 2016 ident: bib17 article-title: Biosynthesis of GPI-anchored proteins: special emphasis on GPI lipid remodeling publication-title: Journal of Lipid Research doi: 10.1194/jlr.R063313 – volume: 378 start-page: 641 year: 2004 ident: bib22 article-title: Effect of glycosylphosphatidylinositol (GPI)-phospholipase D overexpression on GPI metabolism publication-title: Biochemical Journal doi: 10.1042/bj20031326 – volume: 33 start-page: 2458 year: 2014 ident: bib11 article-title: The interaction between uPAR and vitronectin triggers ligand-independent adhesion signalling by integrins publication-title: The EMBO Journal doi: 10.15252/embj.201387611 – volume: 152 start-page: 1145 year: 2001 ident: bib18 article-title: Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin publication-title: The Journal of Cell Biology doi: 10.1083/jcb.152.6.1145 – volume: 284 start-page: 24848 year: 2009 ident: bib7 article-title: The developmentally regulated osteoblast phosphodiesterase GDE3 is glycerophosphoinositol-specific and modulates cell growth publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.M109.035444 – volume: 11 start-page: 23 year: 2010 ident: bib39 article-title: Regulation of cell signalling by uPAR publication-title: Nature Reviews Molecular Cell Biology doi: 10.1038/nrm2821 – volume: 12 start-page: 7 year: 2015 ident: bib42 article-title: The I-TASSER Suite: protein structure and function prediction publication-title: Nature Methods doi: 10.1038/nmeth.3213 – volume: 50 start-page: 411 year: 2011 ident: bib21 article-title: Structural remodeling, trafficking and functions of glycosylphosphatidylinositol-anchored proteins publication-title: Progress in Lipid Research doi: 10.1016/j.plipres.2011.05.002 – volume: 39 start-page: 347 year: 2013 ident: bib12 article-title: Urokinase plasminogen activator receptor: a functional integrator of extracellular proteolysis, cell adhesion, and signal transduction publication-title: Seminars in Thrombosis and Hemostasis doi: 10.1055/s-0033-1334485 – volume: 30 start-page: 548 year: 2016 ident: bib23 article-title: Glycerophosphodiesterase GDE2 Promotes Neuroblastoma Differentiation through Glypican Release and Is a Marker of Clinical Outcome publication-title: Cancer Cell doi: 10.1016/j.ccell.2016.08.016 – volume: 16 start-page: 388 year: 2017 ident: bib24 article-title: Neuronal differentiation through GPI-anchor cleavage publication-title: Cell Cycle doi: 10.1080/15384101.2016.1259894 – volume: 5 start-page: 1303 year: 2015 ident: bib33 article-title: First-in-human uPAR PET: Imaging of Cancer Aggressiveness publication-title: Theranostics doi: 10.7150/thno.12956 – volume: 22 start-page: 5994 year: 2003 ident: bib9 article-title: Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions publication-title: The EMBO Journal doi: 10.1093/emboj/cdg588 – volume: 281 start-page: 998 year: 2014 ident: bib8 article-title: The emerging physiological roles of the glycerophosphodiesterase family publication-title: FEBS Journal doi: 10.1111/febs.12699 – volume: 22 start-page: 1387 year: 2007 ident: bib13 article-title: Urokinase plasminogen activator receptor affects bone homeostasis by regulating osteoblast and osteoclast function publication-title: Journal of Bone and Mineral Research doi: 10.1359/jbmr.070516 – volume: 5 start-page: 107 year: 2015 ident: bib43 article-title: Mapping the topographic epitope landscape on the urokinase plasminogen activator receptor (uPAR) by surface plasmon resonance and X-ray crystallography publication-title: Data in Brief doi: 10.1016/j.dib.2015.08.027 – volume: 92 start-page: 2160 year: 1993 ident: bib32 article-title: A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer publication-title: Journal of Clinical Investigation doi: 10.1172/JCI116817 – volume: 350 start-page: 1092 year: 2015 ident: bib2 article-title: Gene essentiality and synthetic lethality in haploid human cells publication-title: Science doi: 10.1126/science.aac7557 – volume: 267 start-page: 18224 year: 1992 ident: bib16 article-title: Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain publication-title: The Journal of Biological Chemistry doi: 10.1016/S0021-9258(19)37176-5 – volume: 33 start-page: 1017 year: 2016 ident: bib28 article-title: Differentially expressed genes in preimplantation human embryos: potential candidate genes for blastocyst formation and implantation publication-title: Journal of Assisted Reproduction and Genetics doi: 10.1007/s10815-016-0745-x – volume: 91 start-page: 869 year: 1999 ident: bib40 article-title: Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis publication-title: Journal of the National Cancer Institute doi: 10.1093/jnci/91.10.869 – volume: 25 start-page: 349 year: 2007 ident: bib37 article-title: Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis publication-title: Journal of Clinical Oncology doi: 10.1200/JCO.2006.05.6853 – volume: Chapter 12 start-page: Unit 12.5 year: 2001 ident: bib10 article-title: Detection of glycophospholipid anchors on proteins publication-title: Current Protocols in Protein Science doi: 10.1002/0471140864.ps1205s02 – volume: 96 start-page: 4091 year: 2000 ident: bib38 article-title: Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection publication-title: Blood doi: 10.1182/blood.V96.13.4091 – volume: 278 start-page: 43595 year: 2003 ident: bib41 article-title: Novel membrane protein containing glycerophosphodiester phosphodiesterase motif is transiently expressed during osteoblast differentiation publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.M302867200 – volume: 339 start-page: 819 year: 2013 ident: bib6 article-title: Multiplex genome engineering using CRISPR/Cas systems publication-title: Science doi: 10.1126/science.1231143 – volume: 47 start-page: 6991 year: 2008 ident: bib31 article-title: The glycosylphosphatidylinositol anchor: a complex membrane-anchoring structure for proteins publication-title: Biochemistry doi: 10.1021/bi8006324 – volume: 208 start-page: 397 year: 1992 ident: bib35 article-title: A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria publication-title: European Journal of Biochemistry doi: 10.1111/j.1432-1033.1992.tb17200.x – volume: 179 start-page: 1067 year: 2007 ident: bib5 article-title: Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies publication-title: The Journal of Cell Biology doi: 10.1083/jcb.200702151 – volume: 19 start-page: 501 year: 1998 ident: bib34 article-title: Immunohistochemical identification of the receptor for urokinase plasminogen activator associated with fibrin deposition in normal and ectopic human placenta publication-title: Placenta doi: 10.1016/S0143-4004(98)91043-8 – volume: 26 start-page: 915 year: 2009 ident: bib25 article-title: Proteomic scale high-sensitivity analyses of GPI membrane anchors publication-title: Glycoconjugate Journal doi: 10.1007/s10719-008-9116-x – volume: 73 start-page: 2070 year: 2013 ident: bib19 article-title: Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer publication-title: Cancer Research doi: 10.1158/0008-5472.CAN-12-3526 – volume: 374 start-page: 891 year: 2016 ident: bib15 article-title: Soluble Urokinase Receptor and Chronic Kidney Disease publication-title: The New England Journal of Medicine doi: 10.1056/NEJMc1515787 – volume: 16 start-page: R130 year: 2012 ident: bib14 article-title: Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study publication-title: Critical Care doi: 10.1186/cc11434 – volume: 60 start-page: 7126 year: 2000 ident: bib29 article-title: Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy publication-title: Cancer Research – volume: 71 start-page: 392 year: 1994 ident: bib27 article-title: Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysis publication-title: Laboratory Investigation; a Journal of Technical Methods and Pathology – volume: 42 start-page: e168 year: 2014 ident: bib4 article-title: Easy quantitative assessment of genome editing by sequence trace decomposition publication-title: Nucleic Acids Research doi: 10.1093/nar/gku936 – volume: 14 start-page: 2494 year: 2009 ident: bib26 article-title: Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR publication-title: Frontiers in Bioscience doi: 10.2741/3392 – volume: 17 start-page: 1890 year: 2011 ident: bib3 article-title: Clinical applications of the urokinase receptor (uPAR) for cancer patients publication-title: Current Pharmaceutical Design doi: 10.2174/138161211796718233 – volume: 483 start-page: 603 year: 2012 ident: bib1 article-title: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity publication-title: Nature doi: 10.1038/nature11003 – volume: 177 start-page: 927 year: 2007 ident: bib20 article-title: uPAR-induced cell adhesion and migration: vitronectin provides the key publication-title: The Journal of Cell Biology doi: 10.1083/jcb.200612058 – volume: 339 start-page: 324 year: 2013 ident: bib30 article-title: GDE2 promotes neurogenesis by glycosylphosphatidylinositol-anchor cleavage of RECK publication-title: Science doi: 10.1126/science.1231921 – volume: 252 start-page: 446 year: 1991 ident: bib36 article-title: Primary structure and functional activity of a phosphatidylinositol-glycan-specific phospholipase D publication-title: Science doi: 10.1126/science.2017684 – reference: 27860541 - Cell Cycle. 2017 Mar 4;16(5):388-389 – reference: 23400595 - Cancer Res. 2013 Apr 1;73(7):2070-81 – reference: 26962914 - N Engl J Med. 2016 Mar 3;374(9):891 – reference: 21711239 - Curr Pharm Des. 2011;17(19):1890-910 – reference: 11110678 - Blood. 2000 Dec 15;96(13):4091-5 – reference: 18330699 - Glycoconj J. 2009 Nov;26(8):915-21 – reference: 11257116 - J Cell Biol. 2001 Mar 19;152(6):1145-57 – reference: 19596859 - J Biol Chem. 2009 Sep 11;284(37):24848-56 – reference: 18557633 - Biochemistry. 2008 Jul 8;47(27):6991-7000 – reference: 25300484 - Nucleic Acids Res. 2014 Dec 16;42(22):e168 – reference: 12933806 - J Biol Chem. 2003 Oct 31;278(44):43595-602 – reference: 24373430 - FEBS J. 2014 Feb;281(4):998-1016 – reference: 21658410 - Prog Lipid Res. 2011 Oct;50(4):411-24 – reference: 26504891 - Data Brief. 2015 Sep 04;5:107-13 – reference: 18056417 - J Cell Biol. 2007 Dec 3;179(5):1067-82 – reference: 10340907 - J Natl Cancer Inst. 1999 May 19;91(10):869-74 – reference: 26472760 - Science. 2015 Nov 27;350(6264):1092-6 – reference: 27693046 - Cancer Cell. 2016 Oct 10;30(4):548-562 – reference: 22460905 - Nature. 2012 Mar 28;483(7391):603-7 – reference: 14609946 - EMBO J. 2003 Nov 17;22(22):5994-6003 – reference: 23532573 - Semin Thromb Hemost. 2013 Jun;39(4):347-55 – reference: 17548516 - J Cell Biol. 2007 Jun 4;177(5):927-39 – reference: 9778123 - Placenta. 1998 Sep;19(7):501-8 – reference: 23287718 - Science. 2013 Feb 15;339(6121):819-23 – reference: 19273214 - Front Biosci (Landmark Ed). 2009 Jan 01;14:2494-503 – reference: 7933989 - Lab Invest. 1994 Sep;71(3):392-400 – reference: 1381366 - J Biol Chem. 1992 Sep 5;267(25):18224-9 – reference: 25549265 - Nat Methods. 2015 Jan;12(1):7-8 – reference: 17539736 - J Bone Miner Res. 2007 Sep;22(9):1387-96 – reference: 20027185 - Nat Rev Mol Cell Biol. 2010 Jan;11(1):23-36 – reference: 18429111 - Curr Protoc Protein Sci. 2001 May;Chapter 12:Unit 12.5 – reference: 25168639 - EMBO J. 2014 Nov 3;33(21):2458-72 – reference: 27241529 - J Assist Reprod Genet. 2016 Aug;33(8):1017-25 – reference: 26563290 - J Lipid Res. 2016 Jan;57(1):6-24 – reference: 26516369 - Theranostics. 2015 Sep 13;5(12 ):1303-16 – reference: 11156421 - Cancer Res. 2000 Dec 15;60(24):7126-32 – reference: 23329048 - Science. 2013 Jan 18;339(6117):324-8 – reference: 14611645 - Biochem J. 2004 Mar 1;378(Pt 2):641-8 – reference: 22824423 - Crit Care. 2012 Jul 23;16(4):R130 – reference: 2017684 - Science. 1991 Apr 19;252(5004):446-8 – reference: 1325906 - Eur J Biochem. 1992 Sep 1;208(2):397-404 – reference: 8227331 - J Clin Invest. 1993 Nov;92(5):2160-7 – reference: 17264329 - J Clin Oncol. 2007 Feb 1;25(4):349-55 |
| SSID | ssj0000748819 |
| Score | 2.3730285 |
| Snippet | The urokinase receptor (uPAR) is a glycosylphosphatidylinositol (GPI)-anchored protein that promotes tissue remodeling, tumor cell adhesion, migration and... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| SubjectTerms | Analysis Animals Breast cancer Breast Neoplasms - genetics Breast Neoplasms - metabolism Breast Neoplasms - pathology Cancer Biology Cancer cells Cancer research Cell Adhesion Cell Biology Cell Line, Tumor Cell Proliferation Cell surface Cell Transformation, Neoplastic - genetics Cell Transformation, Neoplastic - metabolism Cell Transformation, Neoplastic - pathology Clustered Regularly Interspaced Short Palindromic Repeats Down-regulation Enzymes Extracellular matrix Female Flow cytometry GDE3 Gene Expression Regulation, Neoplastic Gene Knockout Techniques - methods Glycerophosphodiester phosphodiesterase Glycosylphosphatidylinositol HEK293 Cells Humans Hydrolysis Integrins Isoenzymes - genetics Isoenzymes - metabolism Ligands Localization Medical research Mice Mice, Nude Microscopy Models, Molecular Motility Neoplasm Transplantation Phospholipase C Phospholipases Phosphoric Diester Hydrolases - genetics Phosphoric Diester Hydrolases - metabolism Physiology Proteases Proteins Receptors, Urokinase Plasminogen Activator - antagonists & inhibitors Receptors, Urokinase Plasminogen Activator - genetics Receptors, Urokinase Plasminogen Activator - metabolism RNA, Small Interfering - genetics RNA, Small Interfering - metabolism Rodents Scientific equipment industry Signal Transduction Statistical analysis Thrombolytic drugs Tumor Burden Tumors U-Plasminogen activator Vitronectin Vitronectin - genetics Vitronectin - metabolism Xenografts |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZgCxIX3o-FggzqCSk0D8d2TqitWqiEVqsCUm-W7djbqFWyJLtI_ffMJN6lEYgLh1zsseRoxvON7fE3hOzpJBfM5kUkbFpGLE1MVBiwZWtS40HjEKHbvtiEmM3k-XkxDwduXUir3PjE3lGXjcUz8n0sVwrRNeDZx-WPCKtG4e1qKKFxm-wgUxmbkJ3D49n8bHvKAgApAfOGh3kCoHPffam8-4C06cUIinrG_j_98g1gGidN3kChkwf_O_-H5H6IP-nBYDCPyC1XPyZ3h4qU10_I5cwteipw2g5F6kFttPF03TaXVQ2IB-2YCNO0FF9EYOEJaq6ppp_mpxG-2sTMI7q8aDr4rqoljjiiVU0NJr-vqEUjayleF3RPyfeT429Hn6NQjyGyPM5WkTYM3HSKN4WyZEVpAOl8abRIXOYF4D63nPHM6SKBha1Zz4JdQJ8XpSy0yJ6RSd3U7gWhqZfSaOeYhfCAcwObHObK0nOMUKxMp-T9RjXKBrJyrJlxpWDTgnpUvR5Vr8cp2dsKLweOjr-LHaKOtyJIrN03NO1ChXWqIDyOPWe5EyKGycVGm8TFvGQG2q1PpuQdWohC6owac3MWet116vTrmTqASBLiR16A0G4Q8g3M2sKKtePujYmo4DE69ds-puTtthtHYhZc7Zo1ymRZDp8AmeeDNW7_JpWSQWgJPWJkp6PfHffU1UXPJ57DnpNJ_vLf03pF7qUY0sT4ameXTFbt2r0md-zPVdW1b8LC-wXLYDnW priority: 102 providerName: ProQuest |
| Title | Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28849762 https://www.proquest.com/docview/1950548822 https://www.proquest.com/docview/1933593372 https://pubmed.ncbi.nlm.nih.gov/PMC5576486 https://doaj.org/article/5070f645e7704c60bab1e06d4b70fcf1 |
| Volume | 6 |
| WOSCitedRecordID | wos000408627500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: DOA dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: M~E dateStart: 20120101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: M7P dateStart: 20120101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: 7X7 dateStart: 20120101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: BENPR dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: PIMPY dateStart: 20120101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2050-084X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000748819 issn: 2050-084X databaseCode: M2P dateStart: 20120101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9wwDDdbu8Feyr53XXd4o0-DrPlw7OSxLe12sB6h2-D2ZGzHbkNLciR3g_73k5z0uLDBXvYQP1gKJJJs_ZTIEiGHKkoFM2keCBOXAYsjHeQabNnoWDvQOCB045tNiPk8WyzyYqvVF-aE9eWBe8EdAV4JHWepFSJkhoda6ciGvGQa5o3zgQ-gnq1gyu_BAgwzyvsDeQJc5pH9Wjn7Ccul5yMX5Cv1_7kfbzmkcbLklvc5f0r2BthIj_vHfUYe2Po5edw3krx7QW7m9spX8KZt31sepE0bR9dtc1PV4KhgHvNXmpbiQQbsF0H1HVX0czEL8LAlJgzR5XXTwXVbLfGOU1rVVGPO-ooatI2W4lf-7iX5cX72_fRLMLRRCEBcySpQmsHuGuMPvqxkeanBQblSKxHZxAlw19xwxhOr8gjWo2K-eHUONCfKLFcieUV26qa2bwiNXZZpZS0oAnZYriE2YbYsHUdgYbJ4Qj7eS1aaocY4trq4lRBroBqkV4P0apiQww3zsi-t8Xe2E1TRhgXrYfsJsBI5WIn8l5VMyAdUsMSKFzWm1FypddfJ2bdLeQwAEGAfz4HpYGByDTy1gYVmxuR765DDQu8kdtGFoA9g1oS835DxTkxeq22zRp4kSeESwPO6N6bN28RZxgARAkWMzGz0umNKXV37MuAphIos4_v_Qz5vyZMY8UqIR3IOyM6qXdt35JH5taq6dkoeioXwYzYluydn8-Jy6tcbjBdxgaOAcbeYXRQ_fwNVXDFi |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKAZUL78JCAYPKBSk0D6-dHBAqhdJVl1UFrbQ3Ezv2NmqVLMkuaP8Uv5GZvGgE4tYDh1w8k8hOvnk4ngch27E3FEwPI0doP3GY7yknUoBlrXxl4YuDh66rZhNiMgmn0-hojfxsc2EwrLLViZWiTnKN_8h3sF0peNdgz97OvznYNQpPV9sWGjUsDs3qB2zZyjej9_B9X_r-_ofjvQOn6SrgaO4GCydWDJSNj-ddYcKiRIG-tomKhWcCK8B6cc0ZD0wceQDPmFW1nCOgWZGEUSwCeO4VchX0uMAQMjEV3T8dMMchWNg6DVCAod4x49Sa11ikPeoZvqo_wJ9W4IIZ7IdoXrB5-7f-t7d1m9xsvGu6W4vDHbJmsrvket1vc3WPnE3MrCp0Tgsza_qW0dzSZZGfpRnYcxjHMJ-8oJjvgW01qFrRmH48GjmYk4pxVXR-mpdwnadzvGOPphlVGNq_oBpFqKB4GFLeJyeXstJNsp7lmXlIqG_DUMXGMA3OD-cKtnDMJInl6H_p0B-QVy0UpG5KsWNHkHMJWzLEjaxwIyvcDMh2xzyvK5D8ne0dYqpjwbLh1UBezGSjhSQ4_67lbGiEcGFyroqVZ1yeMAXj2noD8gIRKbEwSIaRR7N4WZZy9OWz3AU_GbxjHgHTVsNkc5i1Bn2k--QWkrLRh6X8jccBed6R8U6M8ctMvkSeIBjCJYDnQY3-bjV-GDJwnIEienLRW26fkqWnVbX0IeyoWcgf_Xtaz8jGwfGnsRyPJoePyQ0fnTcX85O2yPqiWJon5Jr-vkjL4mkl8pR8vWyp-QUkvZTU |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKWcSFfRkoYFC5IIVJHMdODgiVlsKoZTRikXozsWNPo1bJkMyA5q_x63gvyQyNQNx64JCL_RLZyfe2-C2EbKdBJLmJEk8alnmcBdpLNGDZaKYdfHGw0E3TbEKOx_HRUTLZID9XuTAYVrmSiY2gzkqD_8iH2K4UrGvQZ0PXhUVM9vZfz7552EEKT1pX7TRaiBzY5Q9w3-pXoz341s8Z23_7efe913UY8Izww7mXag6Ch-HZV5zxJNMgu12mUxnY0EnQZMIILkKbJgFANeVNXecE5pzM4iSVITz3ArkoeRQhd31gk_X_HVDNMWjbNiVQgtIe2sPc2ZdYsD3pKcGmV8CfGuGMSuyHa57Rf_vX_-c3d4Nc66xuutOyyU2yYYtb5HLbh3N5m5yM7bQpgE4rO-36mdHS0UVVnuQF6HkYx_CfsqKYB4LtNqhe0pS-m4w8zFXFeCs6Oy5ruE7zGd6xS_OCagz5n1ODrFVRPCSp75Av57LTu2SzKAt7n1Dm4lin1nIDRpEQGlw7brPMCbTLTMwG5MUKFsp0JdqxU8ipAlcNMaQaDKkGQwOyvSaetZVJ_k72BvG1JsFy4s1AWU1VJ50UOAW-EzyyUvqwOF-nOrC-yLiGceOCAXmG6FRYMKRAAE3TRV2r0aePagfsZ7CaRQJEWx2RK2HVBuSU6U-v4Kk6OVmr39gckKfrabwTY_8KWy6QJgwjuCTQ3Gs5Yb0bFsccDGqYkT0e6W23P1Pkx00V9Qg8bR6LB_9e1hNyBZhFHY7GBw_JVYY2nY9pS1tkc14t7CNyyXyf53X1uOF-Sr6eN9P8AtVMnaE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Negative+regulation+of+urokinase+receptor+activity+by+a+GPI-specific+phospholipase+C+in+breast+cancer+cells&rft.jtitle=eLife&rft.au=van+Veen%2C+Michiel&rft.au=Matas-Rico%2C+Elisa&rft.au=van+de+Wetering%2C+Koen&rft.au=Leyton-Puig%2C+Daniela&rft.date=2017-08-29&rft.pub=eLife+Science+Publications%2C+Ltd&rft.issn=2050-084X&rft.eissn=2050-084X&rft.volume=6&rft_id=info:doi/10.7554%2FeLife.23649&rft.externalDocID=A623560691 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2050-084X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2050-084X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2050-084X&client=summon |